Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 11/20 | 0.82 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.72 |
| ▸ | USP2 | O75604 | 1/20 | 0.72 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | ACHE | P22303 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.57 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL436090 | 0.91 | HPGD (1.00) | HPGDALDH1A1USP2MAPK1LMNA | |
| SCHEMBL8919062 | 0.91 | HPGD (1.00) | HPGDALDH1A1USP2MAPK1LMNA | |
| SCHEMBL27929296 | 0.91 | HPGD (1.00) | HPGDALDH1A1USP2MAPK1LMNA | |
| SCHEMBL1927946 | 0.91 | HPGD (1.00) | HPGDALDH1A1USP2MAPK1LMNA | |
| SCHEMBL243236 | 0.91 | HPGD (1.00) | HPGDALDH1A1USP2MAPK1LMNA | |
| Bicarbonate SCHEMBL1582960 | 0.89 | HPGD (0.96) | HPGDALDH1A1USP2MAPK1LMNA | |
| Hydrochloric Acid SCHEMBL9209631 | 0.89 | HPGD (0.96) | HPGDALDH1A1USP2MAPK1LMNA | |
| SCHEMBL254870 | 0.89 | HPGD (0.96) | HPGDALDH1A1USP2BLMMAPK1 | |
| SCHEMBL18228404 | 0.89 | HPGD (0.96) | HPGDALDH1A1USP2BLMMAPK1 | |
| SCHEMBL1263133 | 0.85 | HPGD (0.88) | HPGDALDH1A1USP2BLMMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011054628-A1 | ENHANCED PHOTO PROTECTION | UNILEVER PLC (GB) | 2011-05-12 | — | — | WO | disclosed |
| US-20110104082-A1 | ENHANCED PHOTO PROTECTION | CONOPCO, INC., D/B/A UNILEVER (US) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110104082-A1 | ENHANCED PHOTO PROTECTION | ERCC1, PCNA, CUTA | HPGD 322/4885ALDH1A1 902/4885USP2 1225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.